MRI-Guided Focal Laser Ablation for Localized Prostate Cancer: A Single Center Report on Technique and Intermediate-Term Outcomes
Sherif G Nour 1,2 , Tracy E Powell 2,3 , and Peter J Rossi 4,5
Radiology & Imaging Sciences, Emory
University, Atlanta, GA, United States,
MRI Program, Emory University, GA, United States,
& Imaging Sciences, Emory University, GA, United States,
Oncology, Emory University, GA, United States,
of Medicine, Emory University, GA, United States
We report the technical aspects and outcome results of a
minimally-invasive focal treatment using laser ablation
under MRI guidance and monitoring to treat localized
low-intermediate risk prostate cancer while preserving
the rest of the gland. 14 treatment-nave foci of
localized prostate cancer were treated with MRI-guided
and monitored focal laser ablation. The technique is
feasible and well tolerated as an outpatient procedure.
This small series indicates a promising efficacy for up
to 24-month recurrence-free follow-up durations.
Prospective assessment of safety and efficacy awaits
further evaluation on a larger cohort of subjects.
This abstract and the presentation materials are available to members only;
a login is required.